This exciting new FDA cleared and UHMS approved indication comes with important warnings and limitations. From our commentary:
How wonderful that hyperbaric oxygen may now be used to save people’s sight (central retinal artery occlusion) and hearing. But in both instances please note the need for speedy referral to a qualified HBOT practitioner. For sudden hearing loss, according to UHMS, "The best evidence supports the use of HBO2 within two weeks of symptom onset." Also note the clinical evidence does not support the use of hyperbaric oxygen for chronic hearing loss or tinnitus.We urge interested readers to follow our links to the UHMS page on idiopathic sudden sensorineural hearing loss (ISSHL) and the Cochrane Reviews article on ISSHL and tinnitus. Carson McCullers's classic The Heart Is a Lonely Hunter is for extra credit only.